Data Bridge Market Research has recently added a concise research on Global Radiopharmaceuticals Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. Some are the key & emerging players that are part of coverage and have being profiled are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation
Radiopharmaceuticals are drugs that carry a limited degree of radioactivity, and are usually used in nuclear medicine as an alternative to standard radiation for the treatment of certain cancers as well as a diagnostic tool to allow better internal imaging of certain organs and arteries. They are usually able to focus on just one particular part of the body, which can make treatment a lot more effective — not to mention a lot more targeted — than regular radiation, which tends to focus on the entire body.
Analysis of Global Radiopharmaceuticals Market report:
Global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026. In the rise in market can be attributed to increasing prevalence of cancer and cardiovascular chronic diseases, rising health expenditure and technological advancements.
Get Sample Copy of Report Here: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
- Increasing prevalence of cancer and cardiovascular chronic diseases, which is creating need for early diagnosis and treatment
- Rising healthcare expenditure boosts the growth of this market
- Growing awareness about the benefits of radiopharmaceuticals amongst healthcare providers also expands the growth of this market
- Technological advancements an developments which allows the use of radio-labeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors
- Increasing preference of SPECT and PET scans and growing preference of disease targeted cancer therapy
- Stringent regulatory guidelines and high cost of devices using radioisotopes
- Short half-life of radiopharmaceutical
Leading Key players profiled in this report are:
Few of the major market competitors currently working in the radiopharmaceuticals market are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company., Jubilant Pharma. LLC, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Areva Pharma, Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, Curium, among others.
Global Radiopharmaceuticals Market Segmentation:
- Diagnostic Nuclear Medicine
o Spect Radiopharmaceuticals
o Pet Radiopharmaceuticals
- Therapeutic Nuclear Medicine
o Alpha Emitters
o Beta Emitters
o Brachytherapy Isotopes
- Diagnostic Applications
o Spect Applications
o Pet Applications
- Therapeutic Applications
o Bone Metastasis
o Endocrine Tumors
o Other Therapeutic Applications
By Procedural Volume
- Diagnostic Procedures
- Therapeutic Procedures
- Nuclear Reactors
By End User
- Ambulatory Surgical Centers
- Diagnostic Centers
- Cancer Research Institutes
- North America
- South America
Global radiopharmaceuticals market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of radiopharmaceuticals for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Get 20% Extra Discount for Early Buyer, Know More @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market
The Global Radiopharmaceuticals Market report provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading markets players within the Global Radiopharmaceuticals Market. The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users. Market opportunities and recommendations for new investments are also encompassed in this report.
Get Customization and Discount on Report by emailing firstname.lastname@example.org . We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.
Data Bridge Market Research
Find More Reports Related To This Category